This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of vigabatrin: A Synthesis of Findings from 29 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of vigabatrin: A Synthesis of Findings from 29 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Vigabatrin is an antiepileptic drug approved for the treatment of refractory partial epilepsy. 1 , 2 . While initial randomized controlled trials did not detect any major side effects associated with vigabatrin, longer-term observational studies have revealed that its use is linked to asymptomatic visual field constriction. 1 , 2 .

Vigabatrin has also been studied as adjunctive therapy for children with intractable epilepsy. 21 . The study found that vigabatrin was effective in children with intractable epilepsy.

Vigabatrin has been shown to be effective for the treatment of West syndrome. 6 , 27 . West syndrome is an epileptic syndrome that occurs in infancy, characterized by spasms, psychomotor retardation, and an EEG abnormality called hypsarrhythmia. 27 . West syndrome is often resistant to conventional antiepileptic drugs, and vigabatrin is considered a viable treatment option. 6 , 27 . Vigabatrin has shown effectiveness in treating West syndrome alongside valproic acid, benzodiazepines, adrenocorticotropic hormone (ACTH), and corticosteroids. 6 .

Vigabatrin has shown potential as a treatment for epileptic spasms and tonic seizures associated with tuberous sclerosis complex in children beyond infancy. 29 , 17 . Tuberous sclerosis complex is a genetic disorder that causes tumors to develop in various organs, including the brain. 29 . Vigabatrin is recommended as first-line therapy for infantile spasms in tuberous sclerosis complex. 17 .

Vigabatrin has also been found to be effective for children with refractory epilepsy. 7 . Vigabatrin decreased seizure frequency by at least 50% in 33.3% of patients with partial seizures and 30.6% of patients with primary generalized seizures. 7 . Moreover, six of the responders with partial seizures experienced complete resolution of their seizures. 7 .

Vigabatrin has been recommended as a first-line treatment for infantile spasms in many countries, replacing steroids. 10 . However, vigabatrin might not be more effective than steroids, especially corticotropin, particularly in children with tuberous sclerosis. 10 . Due to potential side effects like vision problems, ACTH is recommended as the first-line treatment for West syndrome. 10 .

There is evidence suggesting that vigabatrin might be as effective as ACTH for treating West syndrome. 15 . A randomized, prospective study comparing the effectiveness and relapse rates of ACTH and vigabatrin treatment showed no significant difference. 15 . Both drugs have serious side effects. Further research is needed to determine which drug is more effective. 15 .

Vigabatrin has been compared to carbamazepine as a new antiepileptic drug. 13 . There was no significant difference in effectiveness between vigabatrin and carbamazepine for monotherapy in children with newly diagnosed partial seizures. 13 . The side effects of both drugs were comparable. 13 .

Reasons for Side Effects

The side effects of vigabatrin are believed to stem from its inhibition of GABA (γ-aminobutyric acid) breakdown in the brain. 3 . GABA is an inhibitory neurotransmitter in the brain, responsible for suppressing nerve cell activity. 3 . When vigabatrin inhibits GABA breakdown, the concentration of GABA in the brain increases, which is thought to lead to side effects such as vision problems. 3 .

Common Side Effects

Vision Problems

Vigabatrin can cause vision problems. 1 , 2 , 9 , 6 , 28 , 5 , 22 , 24 . Asymptomatic visual field constriction is the most common vision problem associated with vigabatrin. However, symptoms such as reduced vision and visual field defects can also occur. 1 , 2 , 9 , 6 , 28 , 5 , 22 . Vision problems caused by vigabatrin can develop weeks to years after starting the medication. 1 , 2 , 9 . While stopping vigabatrin can improve vision problems, complete recovery is not guaranteed. 9 , 6 .

Weight Gain

Vigabatrin can cause side effects such as increased appetite and weight gain. 7 , 16 . Weight gain from vigabatrin is thought to be related to its effect on raising GABA levels in the brain. 16 . Since GABA plays a role in suppressing appetite, increasing its levels with vigabatrin could lead to increased appetite and subsequent weight gain. 16 .

Rash

Vigabatrin can trigger skin reactions, including rashes. 17 .

Behavioral Changes

Vigabatrin may cause behavioral changes as a side effect. 17 .

Side Effect Management

Vision Problems

It's recommended to undergo an eye exam before starting vigabatrin treatment. 5 . Regular eye exams during treatment are essential. 5 . If vision problems are detected, discontinuing vigabatrin may be necessary. 9 , 6 .

Weight Gain

Dietary and exercise interventions are recommended while taking vigabatrin. 16 . If weight gain associated with vigabatrin is a concern, consulting with a doctor is crucial. 16 .

Study Comparisons

Commonalities

Multiple studies have indicated that vigabatrin is effective for treating refractory epilepsy. 1 , 21 , 7 , 2 .

Differences

Certain studies have shown variations in the effectiveness and side effects of vigabatrin. 10 , 15 . For instance, vigabatrin might not always be more effective than steroids. 10 . While vigabatrin can cause side effects like vision problems, some studies suggest a lower risk of visual field defects associated with the drug. 6 .

Practical Implications

Vigabatrin is a valuable medication for treating refractory epilepsy, but it has the potential to cause vision problems and other side effects. 1 , 2 , 9 . When taking vigabatrin, it's vital to follow your doctor's instructions carefully and undergo regular eye exams. 5 . If you experience any symptoms such as vision problems, contact your doctor immediately. 9 .

Current Research Limitations

Research on the side effects of vigabatrin is still insufficient. 24 . Long-term effects of vigabatrin remain largely unknown. 24 .

Future Research Directions

Further research on the side effects of vigabatrin is necessary. 24 . Specifically, research needs to focus on the long-term effects of vigabatrin and methods to mitigate the risk of vision problems. 24 .

Conclusion

Vigabatrin is an effective medication for treating refractory epilepsy, but it can cause vision problems and other side effects. 1 , 2 , 9 . Always follow your doctor's instructions and get regular eye exams when taking vigabatrin. 5 . Further research is needed on the side effects of vigabatrin. 24 .


Keywords
Benefit Keywords
Risk Keywords
Literature analysis of 29 papers
Positive Content
23
Neutral Content
4
Negative Content
2
Article Type
1
4
4
17
29

Language : English


Language : English


Language : English


Language : Japanese


Language : English


Language : Serbian


Language : English


Language : English


Language : English


Language : English


Language : Croatian


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : German


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.